Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease (IBD), including Crohn’s Disease and Ulcerative Colitis

Overview of Irritable Bowel Syndrome (IBS):

IBS is a common gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits.

 

Prevalence in the United States ranges from 7% to 16%, with higher occurrence in women and young individuals.

 

Annual direct costs associated with IBS exceed $1 billion in the United States.

 

Traditionally, IBS diagnosis relies on symptom identification related to various IBS subtypes (e.g., IBS with diarrhea, IBS with constipation, functional diarrhea, etc.).

 

Dysfunctions in gastrointestinal motor and sensory mechanisms contribute to IBS symptoms.

 

Alarm symptoms (e.g., unintentional weight loss, rectal bleeding) should be excluded during diagnosis1.

 

Diagnosis and Management:

 

Symptom-based diagnosis involves assessing abdominal pain, bowel dysfunction, and bloating.

 

Additional history for somatoform and psychological disorders is valuable.

 

Physical examination (including digital rectal examination) and screening tests help exclude organic

Hyperbaric Oxygen Therapy (HBOT) for IBD: A Brief Overview

Lets look at these studies related to hyperbaric oxygen therapy (HBOT) and its effectiveness in treating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.

Accumulating evidence suggests that HBOT may be effective for IBD. A systematic review analyzed 19 studies involving 809 patients. Here are the key findings:

Clinical Remission Rates:

Ulcerative Colitis: 87% clinical remission rate

Luminal Crohn’s Disease: 88% clinical remission rate

Perianal Crohn’s Disease: 60% clinical remission rate

Pouch Disorders: 31% clinical remission rate

Pyoderma Gangrenosum: 92% clinical remission rate

Perianal Sinus/Metastatic Crohn’s Disease: 65% clinical remission rate

Safety:

15% of patients experienced minor adverse events.

Conclusion:

Additional Studies:

Click Here for study 2

Clinical Studies

These research articles underscores the benefits of hyperbaric oxygen therapy for individuals with Inflammatory Bowel Disease (IBD), including Crohn’s Disease and Ulcerative Colitis. .

If you have questions about a particular symptom or condition related to inflammatory bowel disease (IBD) , feel free to ask!

The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.

GET AN HBOT CHAMBER FOR YOUR CLINIC OR HOME

GET MORE INFORMATION!

Learn about purchase and rental programs.

Newtowne 34″ Newtowne Hyperbaric Chamber

Copyright © 2024 Hyperbaric Hub LLC   All Rights Reserved